Vestas targets an EBIT margin of at least 10%, which will be challenging due to competitive rivalry among participants and the threat of Chinese entrants, whose turbine capabilities match their ...
Idexx Laboratories benefits from operating in the resilient pet healthcare industry. The company's razor-and-blade business model adds a degree of stability for investors. Idexx is soon to expand into ...